Logo image
Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain
Journal article   Peer reviewed

Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain

Gabrielle Campbell, Emily Stockings and Suzanne Nielsen
European Archives of Psychiatry and Clinical Neuroscience, Vol.269, pp.135-144
2019
PMID: 30635715
url
https://doi.org/10.1007/s00406-018-0960-9View
Published Version

Abstract

Neurosciences Cannabis Medicine & Public Health Cannabis-based medicines Psychiatry Chronic pain Medical cannabis
The use of medical cannabis and cannabis-based medicines has received increasing interest in recent years; with a corresponding surge in the number of studies and reviews conducted in the field. Despite this growth in evidence, the findings and conclusions of these studies have been inconsistent. In this paper, we outline the current evidence for medical cannabis and cannabis-based medicines in the treatment and management of chronic non-cancer pain. We discuss limitations of the current evidence, including limitations of randomised control trials in the field, limits on generalisability of previous findings and common issues such as problems with measurements of dose and type of cannabinoids. We discuss future directions for medicinal cannabinoid research, including addressing limitations in trial design; developing frameworks to monitor for use disorder and other unintended outcomes; and considering endpoints other than 30% or 50% reductions in pain severity.

Details

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Clinical Neurology
Psychiatry

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image